ASAM Practice Pearls
ASAM Practice Pearls
ASAM Education
Individualizing Buprenorphine: Low-dose Induction to Long-acting Injectables
26 minutes Posted Jul 13, 2026 at 9:00 am.
Introduction
Patient Case: Erratic use of Buprenorphine
Deciding Between Traditional and Low-Dose Induction
Direct-to-Inject Approach and Access Logistics
Low-dose Induction Approach
Considerations for Tailoring Buprenorphine Doses
Candidates for LAI Formulations
Initiating LAI Treatment
Managing Ongoing Use and Breakthrough Symptoms on LAI
Addressing Co-occurring Substance Use Disorders
Practice Pearls
Conclusion and Additional Learning Opportunity
0:00
26:20
Download MP3
Show notes
In this episode of ASAM Practice Pearls, Dr. Stephen Taylor hosts Dr. Stephen Holt in a discussion about practical strategies for initiating and managing patients receiving low-dose buprenorphine and long-acting injectable (LAI) formulations. The conversation explores how to match induction approaches to individual patient needs, guidance on dosing, and ways to support ongoing use, cravings, or withdrawal symptoms. This episode offers listeners practical insights for implementing buprenorphine treatment strategies and expanding access to evidence-based care.